BUYINS.NET: CCOW, LJPC, ARSC, MKGAY, WTKWY Have Been Removed From Naked Short List Today

Mar 16, 2009 (M2 PRESSWIRE via COMTEX) --
WTKWY | Quote | Chart | News | PowerRating -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list: Capital Corp of the West (NASDAQ: CCOW | Quote | Chart | News | PowerRating), La Jolla Pharmaceutical Company (NASDAQ: LJPC | Quote | Chart | News | PowerRating), American Security Resources Corporation (OTCBB: ARSC | Quote | Chart | News | PowerRating), Merck Kommanditgesellschaft auf Aktien (OTC: MKGAY | Quote | Chart | News | PowerRating), Wolters Kluwer NV (OTC: WTKWY). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.

Capital Corp of the West (NASDAQ: CCOW | Quote | Chart | News | PowerRating) operates as the bank holding company for County Bank, which provides general commercial banking products and services primarily in California. The company offers demand, savings, and time deposits. Its loan portfolio includes commercial, agriculture, real estate, personal, home improvement, home mortgage, automobile, credit card, and other installment and term loans. The company also offers Internet banking, sweep accounts, lockbox, positive pay, remote deposit service, safe deposit boxes, banking-by-mail, drive-up facilities, automated teller machines, trust services, and other customary banking services. As of August 18, 2008, it operated 39 branch offices, primarily in Fresno, Kings, Madera, Mariposa, Merced, Sacramento, San Bernardino, San Francisco, San Joaquin, Stanislaus, Santa Clara, Tulare, and Tuolumne counties. The company was founded in 1977 and is headquartered in Merced, California. With 10.82 million shares outstanding and 524,800 shares declared short as of January 2009, there is no longer a failure to deliver in shares of CCOW. According to quarterly data provided by the SEC, there were still 172,519 shares of CCOW that were failing-to-deliver as of June 30, 2008.

La Jolla Pharmaceutical Company (NASDAQ: LJPC | Quote | Chart | News | PowerRating) a biopharmaceutical company, develops pharmaceutical products to treat patients with lupus. The company's lead product in development is Riquent, which is in Phase 3 ASPEN clinical trials to treat patients with lupus. The Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues. It also discovers and develops orally-active small molecules for the treatment of autoimmune diseases, and acute and chronic inflammatory disorders. The company was founded in 1989 and is based in San Diego, California. With 55.42 million shares outstanding and 63,100 shares declared short as of January 2009, there is no longer a failure to deliver in shares of LJPC. According to quarterly data provided by the SEC, there were still 2,142,704 shares of LJPC that were failing-to-deliver as of June 13, 2005.

American Security Resources Corporation (OTCBB: ARSC | Quote | Chart | News | PowerRating) through its subsidiaries, focuses on the development and commercialization of hydrogen fuel cells and related clean energy technologies. The company also involves in negotiating the acquisition manufacturing and intellectual property for residential wind turbines that spin in a horizontal plane; and developing and commercializing a technology to formulate hydrogen from ammonia-to-hydrogen catalytic electrolyzer technology. In addition, it entered into a sponsored research agreement with Ohio University to develop commercial electrolyzer technology and ammonia-to-hydrogen fueling system for vehicles. The company, formerly known as Kahuna Network Security, Inc., was founded in 1981 and is based in Houston, Texas. With 297.80 million shares outstanding and an undisclosed short position, there is no longer a failure to deliver in shares of ARSC. According to quarterly data provided by the SEC, there were still 1,635,944 shares of ARSC that were failing-to-deliver as of August 25, 2006.

Merck Kommanditgesellschaft auf Aktien (OTC: MKGAY | Quote | Chart | News | PowerRating) develops, manufactures, and markets pharmaceutical products and laboratory chemicals worldwide. The Merck Serono division primarily offers various prescription drugs, including Erbitux for metastatic colorectal, head, and neck cancer; UFT for colorectal cancer; Rebif for multiple sclerosis; Gonal-f Ovitrelle Pergoveris, Luveris, Crinone, and Cetrotide for infertility; Saizen for growth hormone disorders; Serostim for HIV-associated wasting; the Glucophage family for type 2 diabetes; the Concor family for cardiovascular diseases; Euthyrox for thyroid disorders; Raptiva for psoriasis; and Cyanokit for cyanide poisoning. The Consumer Health Care division offers over-the-counter products for preventive health care and self-treatment of minor ailments. Its product portfolio includes products to strengthen the joints under the Seven Seas brand; the vitamin products Cebion, Bion 3 (Multibionta), and Diabion for everyday health protection; Femibion and Kidabion health brands for women and children; and Nasivin, a cold remedy. The Liquid Crystals division offers liquid crystals and mixtures for use in LCD televisions, computer monitors, notebooks, digital cameras, mobile phones, PDAs, MP3 players, and various other displays. The Performance and Life Science Chemicals division supplies reagents for analysis and other applications; various products for analytical chromatography, microbiology, and food and environmental analysis; and a range of solvents, salts, acids, alkalis, and organic chemicals. It also offers separation and purification materials; ionic liquids; active ingredients used in pharmaceuticals, cosmetics, and sunscreen and skin care products; active ingredients for food supplements; biological crop-enhancing technologies in crop bioscience; and products for technical applications, as well as pigments for various applications. The company was founded in 1668 and is headquartered in Darmstadt, Germany. With 193.86 million shares outstanding and 11,000 shares declared short as of January 2009, there is no longer a failure to deliver in shares of MKGAY. According to quarterly data provided by the SEC, there were still 207,209 shares of MKGAY that were failing-to-deliver as of April 4, 2008.

Wolters Kluwer NV (OTC: WTKWY | Quote | Chart | News | PowerRating) operates as an information services and publishing company. The company operates in four divisions: Health; Corporate and Financial Services; Tax, Accounting, and Legal; Legal, Tax, and Regulatory Europe. The Health division provides marketing and publications services, business intelligence products, and advanced analytical tools and consulting services to support life sciences professionals; and delivers critical information, tools, and workflow solutions at the point-of-care, including drug information, medicine guidelines, synoptic contents, and procedure documentation and coding. It also produces textbooks and point-of-learning systems for healthcare education, as well as reference books and journals for physicians, nurses, students, and allied healthcare professionals; and provides research solutions for academic, medical, and scientific researchers. The Corporate and Financial Services division offers corporate and financial products, services, and solutions, such as content, technology, and analytics in the areas of compliance, litigation, governance, and intellectual property for professionals in legal, banking, securities, and insurance markets. The Tax, Accounting, and Legal division provides research, software, and workflow tools in tax, accounting, audit, and specialized key practice areas in the legal and business compliance markets. The Legal, Tax, and Regulatory Europe division provides information, software, and services to law firms, accounting firms, corporations, and governments for legal, tax and accounting, human resources, public and government administration, health, safety, and environment, and transport. It has operations in North America, Europe, the Asia Pacific, and Latin America. Wolters Kluwer NV was founded in 1889 and is headquartered in Amsterdam, the Netherlands. With 287.09 million shares outstanding and 6,100 shares declared short as of January 2009, there is no longer a failure to deliver in shares of WTKWY. According to quarterly data provided by the SEC, there were still 432,859 shares of WTKWY that were failing-to-deliver as of July 8, 2005.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,450,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

CONTACT: Thomas Ronk, CEO, BUYINS.NET
Tel: +1 800 715 9999
e-mail: Tom@buyins.net
WWW: http://www.buyins.net

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on Merck & Co (MRK) MRK. Merck & Co (MRK) has Short Term PowerRatings at TradingMarkets. Details on Merck & Co (MRK) Short Term PowerRatings is available at This Link.

For full details on La Jolla Pharmaceutical (LJPC) LJPC. La Jolla Pharmaceutical (LJPC) has Short Term PowerRatings at TradingMarkets. Details on La Jolla Pharmaceutical (LJPC) Short Term PowerRatings is available at This Link.

For full details on (MKGAY) MKGAY. (MKGAY) has Short Term PowerRatings at TradingMarkets. Details on (MKGAY) Short Term PowerRatings is available at This Link.

For full details on (ARSC) ARSC. (ARSC) has Short Term PowerRatings at TradingMarkets. Details on (ARSC) Short Term PowerRatings is available at This Link.

For full details on (ARSCE) ARSCE. (ARSCE) has Short Term PowerRatings at TradingMarkets. Details on (ARSCE) Short Term PowerRatings is available at This Link.

For full details on (CCOW) CCOW. (CCOW) has Short Term PowerRatings at TradingMarkets. Details on (CCOW) Short Term PowerRatings is available at This Link.

For full details on (WTKWY) WTKWY. (WTKWY) has Short Term PowerRatings at TradingMarkets. Details on (WTKWY) Short Term PowerRatings is available at This Link.